Search Results 581-590 of 23407 for B cell lymphomas
Han W. Tun, M.D.. Jacksonville, FL. Area of Focus: Bone marrow transplant, Brain lymphoma, Lymphoma, Chronic lymphocytic leukemia, B-cell lymphoma ...
... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...
CAR-T cell therapy, B-cell lymphoma, Lymphoma, Diffuse large b-cell lymphoma, Non-Hodgkin lymphoma, T-cell lymphoma, Cu...taneous t-cell lymphoma, Small ...
Research. Mayo Clinic doctors and scientists are studying ways to improve the diagnosis and treatment of cutaneous T-cell lymphoma. Cancer research is conducted ...
... cell therapy at Mayo Clinic. This research also is published in Blood. Improving response rates for CAR-T cell therapy in B cell lymphoma. “In CAR-T cell ...
Axicabtagene Ciloleucel versus Standard of Care Therapy as First-Line Therapy in High-Risk Large B-Cell Lymphoma. Rochester, Minn., La Crosse, Wis., Mankato ...
... lymphoma, Hodgkin lymphoma, Diffuse large b-cell lymphoma..., Mantle cell lymphoma, Follicular lymphoma, Small lymphocytic lymphoma. Show more areas of focus ...
Mayo Clinic doctors and scientists are studying ways to improve the diagnosis and treatment of cutaneous T-cell lymphoma. Cancer research is conducted in ...
1 cells administered following a conditioning lymphodepletion regimen in diffuse large B cell lymphoma (DLBCL) subjects who failed at least two lines of ...
(MCL), marginal zone lymphoma (MZL), small lymphocytic lymphoma (SLL), chronic lymphocytic leukemia(CLL), diffuse large B-cell lymphoma (DLBCL), or AML a ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.